Finland Healthtech Oura Health Raised $200 Million in Series D Funding at $5.2 Billion Valuation, Investors Include Fidelity & Glucose Monitoring Company Dexcom, Oura Founded in 2013 by Petteri Lahtela, Kari Kivelä & Markku Koskela
26th December 2024 | Hong Kong
Finland healthtech Oura Health has raised $200 million in Series D funding at $5.2 billion valuation, with investors including Fidelity & glucose monitoring company Dexcom. Oura was founded in 2013 by Petteri Lahtela, Kari Kivelä & Markku Koskela. Announcement (19/12/24): “ŌURA, the company behind Oura Ring, the world’s leading smart ring, today announced the completion of a $200 million Series D funding round. Fidelity Management & Research Company and Dexcom, the global leader in glucose biosensing, participated in the round. The investment raises the company’s valuation to $5.2 billion. This financing reflects ŌURA’s momentum in building and leading the smart ring category and the shared belief among its partners and investors that there are substantial growth opportunities ahead. This new capital will enable ŌURA to expand its product offerings, fuel further investment in product, science, and healthcare innovation, including AI, advance global expansion efforts, and explore additional acquisitions to accelerate growth.” ŌURA delivers personalized health data, insights, and daily guidance with Oura Ring, the leading smart ring that helps you live healthier, longer. Guided by a mission of changing the healthcare paradigm from sick care to preventative health, ŌURA makes wellness and recovery a daily practice through sleep, activity, readiness, stress, resilience, women’s health, and heart health. Millions of Oura Members around the world use Oura Ring as a personalized health companion that meets them where they are. ŌURA is building the most scientifically validated wearable; the lightweight and comfortable Oura Ring is validated against medical gold standards and driven by continuous monitoring of 50+ individual health and wellness biometrics and insights. Thousands of teams, research organizations, and concierge medical practices manage the health of their populations with ŌURA, and its ecosystem includes 800+ partners across women’s health, metabolic health, fitness, behavioral health, and more. ŌURA was founded in 2013 in Finland and has offices in Oulu, Helsinki, San Francisco, and San Diego.
“ Finland Healthtech Oura Health Raised $200 Million in Series D Funding at $5.2 Billion Valuation, Investors Include Fidelity & Glucose Monitoring Company Dexcom, Oura Founded in 2013 by Petteri Lahtela, Kari Kivelä & Markku Koskela “
Finland Healthtech Oura Health Raised $200 Million in Series D Funding at $5.2 Billion Valuation, Investors Include Fidelity & Glucose Monitoring Company Dexcom, Oura Founded in 2013 by Petteri Lahtela, Kari Kivelä & Markku Koskela
Sign Up / Register
Caproasia Users
- Manage $20 million to $3 billion of assets
- Invest $3 million to $300 million
- Advise institutions, billionaires, UHNWs & HNWs
Caproasia Platforms | 11,000 Investors & Advisors
- Caproasia.com
- Caproasia Access
- Caproasia Events
- The Financial Centre | Find Services
- Membership
- Family Office Circle
- Professional Investor Circle
- Investor Relations Network
Monthly Roundtable & Networking
Family Office Programs
The 2025 Investment Day
- March - Hong Kong
- March - Singapore
- July - Hong Kong
- July - Singapore
- Sept- Hong Kong
- Sept - Singapore
- Oct- Hong Kong
- Nov - Singapore
- Visit: The Investment Day | Register: Click here
Caproasia Summits
- The Institutional Investor Summit
- The Investment / Alternatives Summit
- The Private Wealth Summit
- The Family Office Summit
- The CEO & Entrepreneur Summit
- The Capital Markets Summit
- The ESG / Sustainable Investment Summit
